# Efficacy and Safety of Intraosseous Antibiotic Prophylaxis in Total Hip Replacement

> **NCT07549542** · PHASE4 · ENROLLING_BY_INVITATION · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 25 (estimated)

## Conditions studied

- Antibiotic Prophylaxis Surgery

## Interventions

- **DRUG:** CeFAZolin 1000 MG
- **DRUG:** Saline (0.9%, sterile, for infusion)

## Key facts

- **NCT ID:** NCT07549542
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-10-20
- **Primary completion:** 2026-10
- **Final completion:** 2026-11
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07549542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07549542, "Efficacy and Safety of Intraosseous Antibiotic Prophylaxis in Total Hip Replacement". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07549542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*